ImmunoPrecise Antibodies (IPA) Short Interest Ratio & Short Volume $0.67 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ImmunoPrecise Antibodies Short Interest DataImmunoPrecise Antibodies (IPA) has a short interest of 96,600 shares, representing 0.45% of the float (the number of shares available for trading by the public). This marks a -4.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 270,055 shares to cover all short positions.Current Short Interest96,600 sharesPrevious Short Interest100,700 sharesChange Vs. Previous Month-4.07%Dollar Volume Sold Short$86,940.00Short Interest Ratio1.1 Days to CoverLast Record DateAugust 15, 2024Outstanding Shares26,315,000 sharesFloat Size21,630,000 sharesShort Percent of Float0.45%Today's Trading Volume29,188 sharesAverage Trading Volume270,055 sharesToday's Volume Vs. Average11% Short Selling ImmunoPrecise Antibodies? Sign up to receive the latest short interest report for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPA Short Interest Over TimeIPA Days to Cover Over TimeIPA Percentage of Float Shorted Over Time Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade ImmunoPrecise Antibodies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/202496,600 shares $86,940.00 -4.1%0.5%1.1 $0.90 7/31/2024100,700 shares $79,452.30 -14.4%0.5%1.4 $0.79 7/15/2024117,700 shares $114,992.90 -15.7%0.6%1.6 $0.98 6/30/2024139,600 shares $140,996.00 -8.0%0.7%1.8 $1.01 6/15/2024151,700 shares $159,285.00 -7.8%0.7%1.7 $1.05 5/31/2024164,600 shares $184,352.00 -18.1%0.8%1.3 $1.12 Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 5/15/2024201,000 shares $230,808.30 -35.5%0.9%0.4 $1.15 4/30/2024311,500 shares $392,490.00 -8.4%1.5%0.5 $1.26 4/15/2024340,000 shares $421,600.00 +6.9%1.6%0.6 $1.24 3/31/2024318,200 shares $483,664.00 -27.8%1.5%0.5 $1.52 3/15/2024440,700 shares $634,608.00 +1,290.2%2.0%0.8 $1.44 2/29/202431,700 shares $58,328.00 -37.6%0.2%0.1 $1.84 2/15/202450,800 shares $100,584.00 +232.0%0.2%0.4 $1.98 1/31/202415,300 shares $27,693.00 -38.3%0.1%0.1 $1.81 1/15/202424,800 shares $41,168.00 +31.2%0.1%0.2 $1.66 12/31/202318,900 shares $32,319.00 -34.8%0.1%0.2 $1.71 12/15/202329,000 shares $40,020.00 +2.1%0.1%0.3 $1.38 11/30/202328,400 shares $44,588.00 -2.1%0.1%0.3 $1.57 11/15/202329,000 shares $42,050.00 -38.3%0.1%0.4 $1.45 10/31/202347,000 shares $108,269.20 +99.2%0.2%0.7 $2.30 10/15/202323,600 shares $30,208.00 -48.3%0.1%0.4 $1.28 9/30/202345,600 shares $83,448.00 +2.9%0.2%1 $1.83 9/15/202344,300 shares $77,968.00 -2.0%0.2%1 $1.76 8/31/202345,200 shares $85,428.00 +52.2%0.2%1.1 $1.89 8/15/202329,700 shares $67,315.05 -24.0%0.1%0.8 $2.27 7/31/202339,100 shares $98,532.00 -22.6%0.2%0.5 $2.52 7/15/202350,500 shares $142,410.00 -3.6%0.2%0.6 $2.82 6/30/202352,400 shares $155,104.00 -46.0%0.2%0.6 $2.96 6/15/202397,000 shares $280,330.00 -1.2%0.4%1.1 $2.89 5/31/202398,200 shares $310,312.00 +0.3%0.4%1.1 $3.16 5/15/202397,900 shares $299,574.00 No Change0.4%1.1 $3.06 10/31/2022129,400 shares $643,118.00 -12.5%N/A8 $4.97 10/15/2022147,800 shares $691,704.00 +41.8%N/A9 $4.68 9/30/2022104,200 shares $415,758.00 +17.6%N/A6.4 $3.99 9/15/202288,600 shares $430,596.00 -19.3%N/A5.6 $4.86 8/31/2022109,800 shares $585,234.00 -29.8%N/A7.4 $5.33 8/15/2022156,400 shares $828,920.00 -16.4%1.0%9.7 $5.30 7/31/2022187,100 shares $791,433.00 -6.7%1.1%11.7 $4.23 7/15/2022200,600 shares $762,280.00 -9.1%1.2%12.7 $3.80 6/30/2022220,600 shares $838,280.00 -4.8%1.3%10.5 $3.80Ex-CIA Advisor: “This is How Kamala will Rig the Election” (Ad)A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…Click here now and learn how to prepare. 6/15/2022231,700 shares $919,849.00 -3.8%1.4%9.2 $3.97 5/31/2022240,800 shares $1.38 million +6.2%1.5%8.1 $5.73 5/15/2022226,800 shares $1.01 million -22.1%1.4%7.4 $4.45 4/30/2022291,300 shares $1.62 million -0.2%1.8%8.5 $5.56 4/15/2022291,900 shares $1.67 million +3.4%1.8%7.8 $5.72 3/31/2022282,200 shares $1.45 million +2.2%N/A0 $5.14 3/15/2022276,200 shares $1.09 million +0.2%1.6%7.5 $3.95 2/28/2022275,600 shares $1.36 million -16.8%1.6%7.5 $4.93 2/15/2022331,400 shares $1.70 million +21.8%1.9%7 $5.13 1/31/2022272,000 shares $1.68 million +16.5%1.6%5.7 $6.18 1/15/2022233,500 shares $1.46 million -24.8%N/A0 $6.26 12/31/2021310,300 shares $1.66 million -12.4%1.8%6 $5.36 12/15/2021354,200 shares $1.91 million +11.2%2.1%5.6 $5.38 11/30/2021318,500 shares $1.91 million +8.9%1.9%4.5 $6.00 11/15/2021292,500 shares $1.78 million -15.0%1.7%3.5 $6.10 10/29/2021344,200 shares $2.26 million -24.2%2.0%2.9 $6.57 10/15/2021454,100 shares $2.99 million +1.3%2.6%2.1 $6.58 9/30/2021448,200 shares $2.79 million -18.3%2.6%0.2 $6.22 9/15/2021548,800 shares $3.62 million -3.1%3.2%0.2 $6.60 8/31/2021566,400 shares $4.18 million -17.1%3.3%0.2 $7.38 8/13/2021682,800 shares $4.81 million +6.9%4.0%0.3 $7.05 7/30/2021638,500 shares $4.20 million +467.6%3.7%0.3 $6.58 7/15/2021112,500 shares $619,875.00 -23.5%0.7%0.1 $5.51 6/30/2021147,000 shares $884,940.00 +18.2%0.9%2.5 $6.02 6/15/2021124,400 shares $931,756.00 -8.0%0.8%1.7 $7.49 5/28/2021135,200 shares $1.06 million +42.3%0.8%1.7 $7.82 5/14/202195,000 shares $712,500.00 +11.8%0.6%1.2 $7.50 4/30/202185,000 shares $878,900.00 +2.8%0.5%0.9 $10.34 4/15/202182,700 shares $904,738.00 +386.5%N/A0 $10.94 3/31/202117,000 shares $150,280.00 +27.8%0.1%0.1 $8.84 3/15/202113,300 shares $153,083.00 -19.9%0.1%0.1 $11.51 2/26/202116,600 shares $222,108.00 +238.8%0.1%0.2 $13.38 2/12/20214,900 shares $68,845.00 -58.5%0.0%0.1 $14.05 1/29/202111,800 shares $200,600.00 +1,375.0%0.1%0.2 $17.00 1/15/2021800 shares $11,992.00 No Change0.0%0 $14.99 IPA Short Interest - Frequently Asked Questions What is ImmunoPrecise Antibodies' current short interest? Short interest is the volume of ImmunoPrecise Antibodies shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 96,600 shares of IPA short. 0.45% of ImmunoPrecise Antibodies' shares are currently sold short. Learn More on ImmunoPrecise Antibodies' current short interest. What is a good short interest ratio for ImmunoPrecise Antibodies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPA shares currently have a short interest ratio of 1.0. Learn More on ImmunoPrecise Antibodies's short interest ratio. What is a good short interest percentage for ImmunoPrecise Antibodies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of ImmunoPrecise Antibodies' floating shares are currently sold short. Is ImmunoPrecise Antibodies' short interest increasing or decreasing? ImmunoPrecise Antibodies saw a decrease in short interest in the month of August. As of August 15th, there was short interest totaling 96,600 shares, a decrease of 4.1% from the previous total of 100,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImmunoPrecise Antibodies' float size? ImmunoPrecise Antibodies currently has issued a total of 26,315,000 shares. Some of ImmunoPrecise Antibodies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmunoPrecise Antibodies currently has a public float of 21,630,000 shares. How does ImmunoPrecise Antibodies' short interest compare to its competitors? 0.45% of ImmunoPrecise Antibodies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImmunoPrecise Antibodies: Omega Therapeutics, Inc. (27.43%), BeyondSpring Inc. (8.94%), Precision BioSciences, Inc. (6.88%), Clearside Biomedical, Inc. (0.24%), Milestone Pharmaceuticals Inc. (0.71%), Leap Therapeutics, Inc. (4.14%), Oncolytics Biotech Inc. (0.82%), Spero Therapeutics, Inc. (0.70%), Entera Bio Ltd. (0.08%), Connect Biopharma Holdings Limited (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short ImmunoPrecise Antibodies stock? Short selling IPA is an investing strategy that aims to generate trading profit from ImmunoPrecise Antibodies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImmunoPrecise Antibodies? A short squeeze for ImmunoPrecise Antibodies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPA, which in turn drives the price of the stock up even further. How often is ImmunoPrecise Antibodies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPA, twice per month. The most recent reporting period available is August, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OMGA Short Squeeze BYSI Short Squeeze DTIL Short Squeeze CLSD Short Squeeze MIST Short Squeeze LPTX Short Squeeze ONCY Short Squeeze SPRO Short Squeeze ENTX Short Squeeze CNTB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IPA) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
